TAS-102 has shown significant antitumor activity in vitro and in xenograft models and can reverse resistance induced by thymidylate synthase (TS) overexpression in cancer cells refractory to 5-fluorouracil (5-FU) [20,21]. The gene discussed is TYMS; the disease is cancer.